0001179110-19-013023.txt : 20191218
0001179110-19-013023.hdr.sgml : 20191218
20191218184154
ACCESSION NUMBER: 0001179110-19-013023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191216
FILED AS OF DATE: 20191218
DATE AS OF CHANGE: 20191218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rabinowitz Matthew
CENTRAL INDEX KEY: 0001646382
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 191293727
MAIL ADDRESS:
STREET 1: C/O NATERA, INC.
STREET 2: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
edgar.xml
FORM 4 -
X0306
4
2019-12-16
0
0001604821
Natera, Inc.
NTRA
0001646382
Rabinowitz Matthew
C/O NATERA, INC., 201 INDUSTRIAL ROAD
SUITE 410
SAN CARLOS
CA
94070
1
1
0
0
Executive Chairman
Common Stock
2019-12-16
4
S
0
28854
37.6992
D
1259461
D
Common Stock
2019-12-16
4
S
0
4479
37.9292
D
1254982
D
Common Stock
2019-12-17
4
S
0
15814
37.2187
D
1239168
D
Common Stock
2019-12-17
4
S
0
17519
37.7497
D
1221649
D
Common Stock
2019-12-18
4
S
0
13656
35.4175
D
1207993
D
Common Stock
2019-12-18
4
S
0
3100
36.3642
D
1204893
D
Common Stock
2019-12-18
4
S
0
100
37.13
D
1204793
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2019.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.90 to $37.895 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.90 to $38.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.60 to $37.59 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.60 to $38.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $36.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.01 to $36.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, attorney-in-fact
2019-12-18